Sonoma Pharmaceuticals (SNOA) Revenue: 2010-2012
Historic Revenue for Sonoma Pharmaceuticals (SNOA) over the last 3 years, with Dec 2012 value amounting to $3.5 million.
- Sonoma Pharmaceuticals' Revenue rose 26.88% to $3.5 million in Q4 2012 from the same period last year, while for Dec 2012 it was $15.5 million, marking a year-over-year increase of 27.79%. This contributed to the annual value of $12.7 million for FY2012, which is 30.65% up from last year.
- Per Sonoma Pharmaceuticals' latest filing, its Revenue stood at $3.5 million for Q4 2012, which was down 21.79% from $4.5 million recorded in Q3 2012.
- Sonoma Pharmaceuticals' Revenue's 5-year high stood at $4.5 million during Q3 2012, with a 5-year trough of $2.3 million in Q2 2010.
- Over the past 3 years, Sonoma Pharmaceuticals' median Revenue value was $2.9 million (recorded in 2011), while the average stood at $3.1 million.
- Data for Sonoma Pharmaceuticals' Revenue shows a peak YoY surged of 48.54% (in 2011) over the last 5 years.
- Over the past 3 years, Sonoma Pharmaceuticals' Revenue (Quarterly) stood at $2.3 million in 2010, then increased by 20.62% to $2.8 million in 2011, then grew by 26.88% to $3.5 million in 2012.
- Its Revenue was $3.5 million in Q4 2012, compared to $4.5 million in Q3 2012 and $4.1 million in Q2 2012.